000 | 01265 a2200337 4500 | ||
---|---|---|---|
005 | 20250517035531.0 | ||
264 | 0 | _c20160429 | |
008 | 201604s 0 0 eng d | ||
022 | _a1748-6963 | ||
024 | 7 |
_a10.2217/nnm.15.27 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSengupta, Aritra | |
245 | 0 | 0 |
_aDelivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles. _h[electronic resource] |
260 |
_bNanomedicine (London, England) _c2015 |
||
300 |
_a1775-84 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLasers |
650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aRNA, Small Interfering _xadministration & dosage |
650 | 0 | 4 |
_aSoot _xadministration & dosage |
700 | 1 | _aMezencev, Roman | |
700 | 1 | _aMcDonald, John F | |
700 | 1 | _aPrausnitz, Mark R | |
773 | 0 |
_tNanomedicine (London, England) _gvol. 10 _gno. 11 _gp. 1775-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/nnm.15.27 _zAvailable from publisher's website |
999 |
_c24988020 _d24988020 |